Accuronix Therapeutics

Accuronix Therapeutics

Dennis Schafer's photo - President & CEO of Accuronix Therapeutics

President & CEO

Dennis Schafer

CEO Approval Rating

80/100

Founded:

2016

Status:

PrivateIndependent Company

ACCURONIX THERAPEUTICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Jacobio Pharma is a top competitor of Accuronix Therapeutics. Jacobio Pharma was founded in Beijing, Beijing Municipality} in 2015. Jacobio Pharma competes in the Biotechnology industry. Compared to Accuronix Therapeutics, Jacobio Pharma generates $ less revenue.

Roivant Sciences is Accuronix Therapeutics's #2 competitor. Roivant Sciences is headquartered in New York, New York, and was founded in 2014. Roivant Sciences competes in the Pharmaceuticals field. Roivant Sciences generates 500% the revenue of Accuronix Therapeutics.

Kymera has been one of Accuronix Therapeutics's top competitors. Kymera is a Public company that was founded in 2016 in Watertown, Massachusetts. Kymera operates in the Biotechnology industry. Compared to Accuronix Therapeutics, Kymera has 45 more employees.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $2M a good estimate for Accuronix Therapeutics's revenue?

Accuronix Therapeutics Acquisitions

No recent acquisitions found related to Accuronix Therapeutics

Accuronix Therapeutics Funding History

$625K

Since Accuronix Therapeutics was founded in 2016, it has participated in 1 round of funding. In total Accuronix Therapeutics has raised $625.0K. Accuronix Therapeutics' funding round was on Jan 2016 for a total of $625.0K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Unattributed
Jan 2016
$625K

BioGenerator

Since Accuronix Therapeutics was founded in 2016, it has participated in 1 round of funding. In total Accuronix Therapeutics has raised $625.0K. Accuronix Therapeutics' funding round was on Jan 2016 for a total of $625.0K

Accuronix Therapeutics Investments

No recent investments found related to Accuronix Therapeutics

Social Media

Accuronix Therapeutics Headquarters

20 South Sarah Street

St. Louis, Montana63108

Driving Directions »

Trending Companies

Accuronix Therapeutics Summary

ABOUT

Overview

Accuronix Therapeutics was founded in 2016. Accuronix Therapeutics' headquarters is located in St. Louis, Montana, USA 63108. It has raised 625.0K in 1 round. The latest round was in Jan 2016. Accuronix Therapeutics' primary investor is BioGenerator....

CEO

Accuronix Therapeutics's President & CEO, Dennis Schafer, currently has an approval rating of 80%. Accuronix Therapeutics's primary competitors are Jacobio Pharma, Roivant Sciences & Kymera.

Website

accuronix.com

Frequently Asked Questions about Accuronix Therapeutics

  1. When was Accuronix Therapeutics founded?

    Accuronix Therapeutics was founded in 2016
  2. Who is Accuronix Therapeutics's CEO?

    Accuronix Therapeutics's CEO is Dennis Schafer
  3. How much revenue does Accuronix Therapeutics generate?

    Accuronix Therapeutics generates $2M in revenue
  4. How much funding does Accuronix Therapeutics have?

    Accuronix Therapeutics has historically raised $625K in funding
  1. Where is Accuronix Therapeutics's headquarters?

    Accuronix Therapeutics's headquarters is in St. Louis Montana, USA
  2. How many employees does Accuronix Therapeutics have?

    Accuronix Therapeutics has 10 employees
  3. What sector does Accuronix Therapeutics operate in?

    Accuronix Therapeutics is in Pharmaceuticals
  4. Who are Accuronix Therapeutics's competitors?

    Accuronix Therapeutics's top competitors are Jacobio Pharma, Roivant Sciences, Kymera